Ian Hunt

Ian Hunt has extensive experience in regulatory affairs within the pharmaceutical industry, currently serving as Head of Drug Development and Senior Vice President of Regulatory Affairs at Akebia Therapeutics since April 2021. Prior to this role, Ian held various positions at GSK, including Vice President of Global Regulatory Affairs for the Therapeutic Group from August 2016 to March 2021. Ian's tenure at AstraZeneca spanned from September 1999 to July 2016, culminating as Vice President of Regulatory Affairs for Cardiovascular, Metabolic Disease, and Neuroscience. Additional experience includes roles at Zeneca K.K. as Regulatory Director/Consultant and as Principal Regulatory Affairs Manager at Zeneca Pharmaceuticals. Ian's career began with ICI Agrochemicals as a Research Chemist, demonstrating a long-standing commitment to regulatory excellence in the pharmaceutical and agrochemical sectors.